Related Experiment Video

Updated: Feb 7, 2026

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model
12:16

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model

Published on: May 18, 2015

11.0K

MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma

Meng-Ya Zhao1, La-Mei Wang2, Jing Liu3

  • 1Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Current Medical Science
|August 4, 2018
PubMed

Insights

MicroRNA-21 (miR-21) promotes esophageal adenocarcinoma metastasis by inhibiting anoikis, a cell death process. Targeting miR-21 may offer a new strategy to prevent cancer spread.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Anoikis, a form of programmed cell death, is crucial for preventing tumor metastasis.
  • MicroRNA-21 (miR-21) is a known oncomiR implicated in tumor progression.
  • Resistance to anoikis is a key factor in cancer cell metastasis.

Purpose of the Study:

  • To investigate the role of miR-21 in anoikis resistance in human esophageal adenocarcinoma (EA).
  • To determine if miR-21 contributes to EA cell metastasis by regulating anoikis.
  • To identify functional targets of miR-21 involved in this process.

Main Methods:

  • Quantitative reverse transcription PCR (qRT-PCR) to measure miR-21 expression.
  • Transfection of miR-21 mimics to induce anoikis resistance.
  • Luciferase assays to validate miR-21 targets (PDCD4 and PTEN).
  • In vivo metastasis experiments using a mouse tail vein injection model.

Main Results:

  • miR-21 expression was significantly upregulated in anoikis-resistant EA cells (OE33/AR).
  • Overexpression of miR-21 conferred anoikis resistance to EA cells.
  • PDCD4 and PTEN were confirmed as functional targets of miR-21.
  • Modulating miR-21 expression affected in vivo metastasis of EA cells in mice.

Conclusions:

  • miR-21 plays a significant role in regulating anoikis in human esophageal adenocarcinoma.
  • Upregulation of miR-21 is associated with lymph node metastasis and poor prognosis in EA patients.
  • Targeting miR-21 presents a potential therapeutic strategy for preventing esophageal adenocarcinoma metastasis.
Keywords:
PDCD4PTENanoikis resistanceesophageal adenocarcinomamiR-21

More Related Videos

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion10:42

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Published on: July 6, 2022

4.2K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.0K

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.5K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
615
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
884
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
672
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
738
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
591